This article has Open Peer Review reports available.
Rapid liver enlargement and hepatic failure secondary to radiographic occult tumor invasion: two case reports and review of the literature
© Simone et al.; licensee BioMed Central Ltd. 2012
Received: 1 February 2012
Accepted: 29 August 2012
Published: 26 November 2012
Unfamiliarity with certain clinical presentations, as illustrated in these cases, can lead to delayed diagnoses that in turn cause increased morbidity, prolonged hospitalization, and the need for autopsy.
In Case 1, a 63-year-old Caucasian woman presented with hepatic enlargement and insufficiency which progressed and resulted in her death over a period of less than 2 weeks. The patient underwent a detailed workup included magnetic resonance imaging and computed tomography scan of her liver, which did not reveal the source of her liver enlargement. Due to her progressive liver enlargement and insufficiency, she developed a life-threatening esophageal variceal bleeding during her hospital stay which further delayed the attainment of her diagnosis. She finally underwent a videoscopic laparotomy and liver biopsy which revealed complete replacement and filling in of the liver sinuous with Indian filing lobular breast cancer. The patient died shortly after her diagnosis and before she could be discharged.
In Case 2, a 68-year-old Caucasian woman with non-small-cell lung cancer was admitted to our Oncology in-patient service with a presentation of rapid hepatic insufficiency and severe liver enlargement. Like the patient in Case 1, during her hospitalization, this patient underwent a thorough radiographic evaluation, including computed tomography and magnetic resonance imaging, to identify the source of her symptoms. Radiographic imaging showed only hepatomegaly and no discrete focal lesions. As the multiple imaging studies over a period of a week did not reveal a clear cause for her symptoms, she finally underwent an interventional radiology core biopsy which showed complete replacement of her liver with non-small-cell lung cancer. Her condition rapidly progressed due to continued liver enlargement and she died due to frank liver failure before her diagnosis was affirmed and she could be discharged.
Both of these cases illustrate the potential difficulties in diagnosing liver-infiltrative malignancy and the need for a high index of clinical suspicion for occult infiltrative malignancy in the liver to determine the appropriate therapeutic intervention, including further treatment of malignancy, palliative care, or determination of candidacy for liver transplantation. Because the diagnosis for the cause of symptoms and hepatomegaly was elucidated only by liver biopsy which occurred much later in their hospital course, both patients died while in the hospital instead of at home or in a hospice. Moreover, these delays in diagnosis and development of morbidities due to the progressing liver failure further prevent any possibility of early initiation of palliative treatment. Initial recognition of this type of presentation can lead to a prompt diagnostic biopsy and diagnosis. Giving the patient a correct diagnosis is one of the fundamental goals of oncology: a goal that, as illustrated in literature review, is not always achieved. Although treatment options in such cases often may be limited, prompt discharge from the hospital and/or admission into a hospice program can potentially afford the patient the best quality of life and help protect the patient’s dignity.
Lung and breast cancer are common cancers that typically present with a dominant primary lesion and metastasis to one of several places, most commonly the brain, bone, liver, and the adrenal glands. Common cancers such as breast or lung present more frequently in an atypical manner than the presentation of an atypical or rare disease. As such, it sometimes takes a high index of suspicion to diagnose these cancers. When these cancers metastasize to other organs, they tend to form discrete lesions that are easily identified by standard radiographic methods, including magnetic resonance imaging (MRI) and computed tomography (CT). However, when the tumor radiographically blends with the normal organ parenchyma, the diagnosis of metastatic disease or recurrence can be difficult. Thus, extensive workup can ensue until a tissue biopsy is obtained. When the organ involved is the liver, the potential for bleeding post-procedure may make the physician disinclined to pursue the biopsy. In this report, we describe two cases involving a 63-year-old Caucasian woman and a 68-year-old Caucasian woman presenting with radiological occult metastasis to the liver to illustrate this point.
A 68-year-old Caucasian patient with a history of breast cancer initially diagnosed 7 years prior was admitted to our Oncology service with worsening abdominal distension. She had had a mastectomy and radiation for local invasive lobular breast cancer 4 years prior, as well as elevation in liver function tests, including aspartate aminotransferase (AST) 150IU/L, alanine aminotransferase (ALT) 233IU/L, alkaline phosphatase of 734IU/L, and bilirubin of 3.4mg/dL. She first had an abdominal CT that showed a significantly enlarged liver, ascites, and no adenopathy or metastasis. An MRI of the liver also showed that the liver was essentially homogenous, with no focal lesions visible.
The patient underwent paracentesis, from which the ascites appeared to be transudative, with no cancer or infectious etiology found. In her third hospital day, she suffered an acute esophageal variceal bleed that prompted her to be admitted to the Intensive Care Unit (ICU) for urgent endoscopy and cauterization. When she returned to the floor, she then underwent a laparoscopic biopsy of the liver that showed infiltrating lobular breast cancer. Lobular carcinoma of the breast is known to grow in a so-called ‘Indian file’ pattern (single rows of cells rather than large clusters or glands). In this case, the tumor was found within vessels and liver sinusoids, giving a homogenous appearance to the patient’s prior imaging studies. The patient died shortly after diagnosis and less than 2 weeks after being admitted with liver failure.
The patient was a 63-year-old Caucasian woman who was initially diagnosed with Stage IIIA adenocarcinoma of the lung. Over the next 4 months, she underwent six cycles of cisplatin and etoposide. Two weeks later, her positron emission tomography (PET)-CT scan showed some mild progression of primary right upper lobe lesions as well as increased supraclavicular lymphadenopathy on the left lobe. The CT scan at that time showed a normal-sized liver, with the size measured at 13cm from dome to tip and a volume of 1194cc.
Four weeks after completing her chemotherapy, she presented to the Emergency department with a two-week history of rapidly worsening right upper quadrant pain and abdominal distension. She reported that it had hurt to cough or sneeze for that period of time. In the Emergency department, her liver enzymes were noted to be moderately elevated at aspartate aminotransferase (AST) 223IU/L, alanine aminotransferase (ALT) 156IU/L, alkaline phosphatase 883IU/L, lipase 20IU/L, total bilirubin 1.6mg/dL, and direct bilirubin 0.8mg/dL. On physical examination, the patient was extremely sensitive to palpation or percussion over the right upper quadrant and along her lower right ribs. Her liver was palpable 4 to 5cm below the costal margin in the midline. Her physical examination showed no signs of splenomegaly, caput medusae, hemorrhoid, or spider angiomas on her chest or neck. Her sclera was anicteric; her examination was otherwise unremarkable.
When a CT scan does not reveal overt signs of metastatic disease but rather a homogeneously appearing liver, as noted in both cases, it is important to have a high index of suspicion for infiltrating cancer. Delays in diagnosis can lead to additional morbidity and mortality if therapy is not initiated early enough. Because the patient in Case 2 had an active cancer, it was more obvious that her liver was impacted by the spread of her disease. However, Case 1 points to the difficulty that occurs when the history of cancer is not necessarily recent. In these cases, it is much harder to diagnose the cause of the liver enlargement, short of a biopsy. In both cases, the patients had poor performance status upon presentation due to the stretching of the liver capsule, resulting in anorexia and weight loss, and progressed rapidly to death. The condition of these patients therefore essentially prevented therapeutic interventions from being pursued. Both cases illustrate the lethality of these diagnoses and the need for prompt recognition to institute a palliative-focused approach if clinically appropriate.
Typically, metastatic disease to the liver manifests with focal lesions noted on standard imaging with CT and MRI. The differential diagnosis for an infiltrative liver process is broad and includes fatty infiltration, drug-induced hepatitis, and viral hepatitis. However, in the two cases described above, metastatic disease may present as an infiltrating malignancy without any focal lesions on radiographic imaging and must be considered in all patients presenting with occult hepatic insufficiency.
Summary of reported cases of radiological occult cancer infiltration of the liver
Prior history of cancer
Other lab test
Nausea, vomiting, abdominal pain
Ductal carcinoma 9 months prior
No abdominal lesions
Anorexia and general fatigue
CT and US
20-fold increased LFTs
Mild fever with elevated LFTs
Elevated LFTs, low plts and HCT
Peripheral T-cell lymphoma
Abdominal pain, decreased appetite
CT and US
Hepatomegaly and ascites
Small-cell lung cancer
Worsening ascites, jaundice, and hematochezia
Breast cancer 9 years prior
Probable benign cysts, ascites
Poorly differentiated adenocarcinoma
Altered liver test
CT and US
Heterogeneous liver parenchyma
Breast lobular carcinoma
Clinical signs of hepatocellular injury
Renal cell carcinoma
Renal cell carcinoma
Anorexia and abdominal distension
US and CT
Hepatomegaly and ascites
Abnormal liver function
CT and MRI
Marked liver enlargement, no lesions
Small-cell lung cancer
Acute hepatic failure
Metastatic prostatic carcinoma.
No liver metastatic disease
Acute severe hepatic failure
CT and US
Homogeneous enlarged liver, no ascites
Bili 9.1, increase LFTs
Small cell carcinoma
Infants with hepatosplenomegaly
No biogenic amines
Miyaaki et al. describes a case of disseminated small-cell lung cancer (SCLC) that resulted in fulminant hepatic failure (FHF). Imaging by both CT and MRI of the abdomen showed marked, rapidly progressing hepatomegaly; however, no nodular lesions were visible in the liver, similar to Case 2. At autopsy, there was almost complete parenchymal replacement with metastatic tumor in the liver. Furthermore, these cases also highlight the important point that neoplastic involvement of the liver should be considered in the differential diagnosis of rapid hepatic enlargement with or without FHF of unknown etiology. Gilbert et al. reported an almost identical clinical scenario with another patient who presented with diffuse radiographic occult hepatic involvement that led to the rapid death of the patient without a definitive diagnosis. At autopsy, the patient’s liver was grossly enlarged and weighed 5200g. It was slightly nodular and mottled in appearance but not cirrhotic. Bilirubin congestion and fatty changes were present, but the ducts were patent. Diffuse, white pinpoint plaques were noted throughout the parenchyma and by light microscopy were found to contain massive and diffuse infiltration by metastatic SCLC with concurrent hepatic necrosis.
Another case of occult SCLC involvement of the liver resulting in FHF was reported by Rajvanshi. As with the previously described cases, this patient, at autopsy, was found to have on gross examination an enlarged liver weighing 3400g with a ‘salt and pepper’ distribution of metastases and no evidence of normal liver parenchyma. By light microscopy, few hepatocytes were noted and near-complete parenchyma replacement with metastatic small cell carcinoma, undifferentiated oat cell, bronchogenic type, was observed. Rajvanshi also reported a case of lymphoma involvement of the liver that was also radiographically occult and resulted in rapid patient death from hepatic failure. Similarly, Kim et al. and Trudel et al. found that lymphoma can occur primarily in the liver, and in roughly 10% of these cases, it is radiographically occult and not detected until a biopsy is performed[12, 13].
In Nascimento, a 59-year-old otherwise healthy man presented initially with expressive aphasia and visual field deficits and was subsequently diagnosed with a left bladder trigone mass. He was later determined to have renal cell carcinoma and underwent right nephrectomy. At that time, his liver appeared normal on imaging. However, he was admitted a year later for worsening renal function with elevation in hepatic enzymes. Imaging via ultrasound showed a heterogeneous, although enlarged, liver. There was increased signal of the entire liver noted on MRI. Subsequently, the patient underwent exploratory laparotomy where gross examination by the surgeon failed to reveal evidence of malignancy; however, biopsy of the liver showed metastatic renal cell carcinoma. Shan describes a case of diffuse liver infiltration by melanoma of unknown primary origin in a 62-year-old woman who presented with hepatomegaly and ascites; her CT and MRI scans demonstrated hepatomegaly without any focal lesions. She had a comprehensive workup for malignancy. Finally, subsequent liver biopsy, as her prior extensive workup was unrevealing, was found to contain intrasinusoidal infiltration by malignant melanoma cells with an unknown primary.
When hepatic involvement occurs with tumors, the degree of hepatic enzyme elevation varies upon presentation, but is often found to correlate with the degree of intrasinusoidal hepatic involvement. In severe cases with rapidly growing tumors, patients can present with FHF and subsequent multisystem organ failure as a result of homogenous infiltration of the liver by metastatic disease. Shakir presented a case of metastatic prostate adenocarcinoma in which a 68-year-old man presented with FHF. An abdominal CT scan revealed hepatomegaly without focal lesions, and Doppler ultrasound showed hepatomegaly and hepatic steatosis. The patient’s condition rapidly declined, with multiorgan system failure necessitating emergent ICU interventions. Autopsy revealed an enlarged liver weighing 3478g, with the biopsy showing intravascular and intraparenchymal widespread metastatic prostatic adenocarcinoma.
Common to all of these cases is that both CT and MRI imaging failed to diagnose metastatic disease, as no discrete masses or focal lesions were readily identifiable. In all instances, a biopsy was necessary to confirm the diagnosis of infiltrative metastatic disease. This is important because FHF is frequently caused by etiologies other than cancer: typically, and in the majority of patients, by viral hepatitis or drug toxicities. In 20% to 40% patients with FHF, no cause is determined, despite extensive exhaustive workup. As liver transplantation can provide long-term benefit for patients, it is important to reach a definitive diagnosis and identify the cause, since liver transplantation is contraindicated in malignant infiltration of the liver because these patients will develop further metastatic disease after transplantation. Rojter et al. provided a testament to this situation in their review, where three patients were referred for liver transplantation after negative radiographic workup via CT and ultrasound for liver failure. In each case, before or after liver transplantation, biopsy revealed that each case had vascular tumors present in the liver, either angiosarcoma or hemangioendothelioma. In these cases, where vascular tumors were involved, MRI can help with the diagnosis, as two of the three cases were suspected to have tumor burden in the liver after MRI imaging. Radiographically undetected involvement of abdominal organs, including the liver, is not uncommon with many different tumor types, as summarized in Table1. Winkelmann conducted a correlation study of abdomen CT imaging with autopsy findings in patients with malignant tumors, finding that CT scans missed between 5 and 10% of metastatic lesions. This is confirmed in this report, as breast cancer, lung cancer, and sarcomas can massively involve the liver but remain radiographically occult. Unfortunately for many of these patients, these critical biopsies and subsequent diagnosis had to await postmortem examination, given the rapid progression of malignancy resulting in death. This may be inconsequential, as this overwhelming tumor involvement of the liver is inevitably fatal.
This case series highlights the not-infrequent occurrence of radiographic occult cancers in the liver that can present to both the family medicine practitioner and the seasoned oncologist.
Experience and familiarity with this type of presentation can foster the necessary high index of clinical suspicion that can prevent misdiagnosis in patients who present with hepatomegaly, occult hepatic insufficiency, or rapidly progressing pain without an obvious explanation. If this type of presentation is initially recognized, a diagnostic biopsy can quickly occur and help overcome the clinical hesitation to biopsy a swollen and enlarged liver. It also helps avoid the need for an autopsy, which unfortunately is all too common, as demonstrated by our literature review, where many diagnoses were only made postmortem. Moreover, not deferring or delaying a diagnostic biopsy can prevent undue clinical deterioration due either to the rapid progression of the untreated cancer or the cancer’s associated morbidity, such as GI bleeding, leading to prolonged hospital stays and admission to the ICU. Since aggressive treatment-based options are often poorly tolerated and ineffective in such cases, transition to an outpatient palliative approach and comfort care is often warranted, as evidenced in Case 2, if pain control can be achieved. In summary, then, quick recognition of this diagnosis and confirmatory biopsy will usually lead to the best available outcome for the patient.
Written informed consent was obtained as proscribed by the University of Florida Institutional Review Board (IRB) from either the patient’s or the patients’ next of kin for publication of this manuscript and accompanying images. A copy of the written consents are available for review by the Editor-in-Chief of this journal. This case report follows the guidelines and policies of the University of Florida IRB.
- Allison KH, Fligner CL, Parks WT: Radiographically occult, diffuse intrasinusoidal hepatic metastases from primary breast carcinomas: a clinicopathologic study of 3 autopsy cases. Arch Pathol Lab Med. 2004, 128: 1418-1423.PubMedGoogle Scholar
- Graber I, Dumortier J, Poncet G, Queneau PE, Mathevet P, Scoazec JY: Hepar lobatum carcinomatosum revealing an occult metastatic lobular carcinoma of the breast. Ann Diagn Pathol. 2010, 14: 438-442. 10.1016/j.anndiagpath.2009.10.004.View ArticlePubMedGoogle Scholar
- Martelli O, Coppola L, De Quarto AL, Palma M, Sarmiento R, Foggi CM: Fulminant hepatic failure caused by diffuse intrasinusoidal metastatic liver disease: a case report. Tumori. 2000, 86: 424-427.PubMedGoogle Scholar
- Goswami R, Babich M, Farah KF: Occult breast malignancy masquerading as acute hepatic failure. Gastroenterol Hepatol (N Y). 2011, 7: 62-65.Google Scholar
- Nazario HE, Lepe R, Trotter JF: Metastatic breast cancer presenting as acute liver failure. Gastroenterol Hepatol (N Y). 2011, 7: 65-66.Google Scholar
- Platt MS, Agamanolis DP, Krill CE, Boeckman C, Potter JL, Robinson H, Lloyd J: Occult hepatic sinusoid tumor of infancy simulating neuroblastoma. Cancer. 1983, 52: 1183-1189. 10.1002/1097-0142(19831001)52:7<1183::AID-CNCR2820520710>3.0.CO;2-M.View ArticlePubMedGoogle Scholar
- Lanzas Prieto JM, de la Campa JM A, Guate Ortiz JL, Gonzalez Tuero J, Perez Garcia FJ, Gutierrez Garcia R, Gonzalez Naranjo F: Fulminant hepatic insufficiency caused by diffuse intrasinusoidal liver metastases in a patient with transitional-cell carcinoma of the bladder. Arch Esp Urol. 2002, 55: 547-551.PubMedGoogle Scholar
- Alcalde M, Garcia-Diaz M, Pecellin J, Pijierro A, Sanchez P, Soria R, de Santamaria JS: Acute liver failure due to diffuse intrasinusoidal metastases of urothelial carcinoma. Acta Gastroenterol Belg. 1996, 59: 163-165.PubMedGoogle Scholar
- Miyaaki H, Ichikawa T, Taura N, Yamashima M, Arai H, Obata Y, Furusu A, Hayashi H, Kohno S, Nakao K: Diffuse liver metastasis of small cell lung cancer causing marked hepatomegaly and fulminant hepatic failure. Intern Med. 2010, 49: 1383-1386. 10.2169/internalmedicine.49.3296.View ArticlePubMedGoogle Scholar
- Gilbert J, Rutledge H, Koch A: Diffuse malignant infiltration of the liver manifesting as a case of acute liver failure. Nat Clin Pract Gastroenterol Hepatol. 2008, 5: 405-408.View ArticlePubMedGoogle Scholar
- Rajvanshi P, Kowdley KV, Hirota WK, Meyers JB, Keeffe EB: Fulminant hepatic failure secondary to neoplastic infiltration of the liver. J Clin Gastroenterol. 2005, 39: 339-343. 10.1097/01.mcg.0000155123.97418.06.View ArticlePubMedGoogle Scholar
- Kim HS, Ko YH, Ree HJ: A case report of primary T-cell lymphoma of the liver. J Korean Med Sci. 2000, 15: 240-242.View ArticlePubMedPubMed CentralGoogle Scholar
- Trudel M, Aramendi T, Caplan S: Large-cell lymphoma presenting with hepatic sinusoidal infiltration. Arch Pathol Lab Med. 1991, 115: 821-824.PubMedGoogle Scholar
- Nascimento AB, Mitchell DG, Rubin R, Weaver E: Sinusoidal spread of liver metastases from renal cell carcinoma: simulation of diffuse liver disease on MR imaging. Abdom Imaging. 2002, 27: 196-198. 10.1007/s00261-001-0065-0.View ArticlePubMedGoogle Scholar
- Shan GD, Xu GQ, Chen LH, Wang ZM, Jin EY, Hu FL, Li YM: Diffuse liver infiltration by melanoma of unknown primary origin: one case report and literature review. Intern Med. 2009, 48: 2093-2096. 10.2169/internalmedicine.48.2542.View ArticlePubMedGoogle Scholar
- Shakir FA, Madhoun M, Whorton J, Harty R: Metastatic prostatic carcinoma presenting as fulminant hepatic failure. South Med J. 2008, 101: 1049-1050. 10.1097/SMJ.0b013e31817c74c3.View ArticlePubMedGoogle Scholar
- Anthuber M, Jauch KW, Briegel J, Groh J, Schildberg FW: Results of liver transplantation for gastroenteropancreatic tumor metastases. World J Surg. 1996, 20: 73-76. 10.1007/s002689900013.View ArticlePubMedGoogle Scholar
- Rojter S, Villamil FG, Petrovic LM, Silverman JM, Woolf GM, Podesta LG, Makowka L, Vierling JM: Malignant vascular tumors of the liver presenting as liver failure and portal hypertension. Liver Transpl Surg. 1995, 1: 156-161. 10.1002/lt.500010304.View ArticlePubMedGoogle Scholar
- Winkelmann M, Schoppe WD, Volk N, Burrig KF, Jungblut RM, Schneider W: Correlation of abdominal CT imaging with autopsy findings in patients with malignant tumors. J Cancer Res Clin Oncol. 1987, 113: 279-284. 10.1007/BF00396386.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.